Page 77 - Eshre 2018

Onco‐ Fertility Preservation
Age at vitrification
100 90 80 70 60 50 40 30 20 10
0 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 46 Total 2 3 5 8 9 10 17 8 17 15 20 23 29 36 38 36 71 63 68 79 69 71 92 70 60 40 18 21 4 4 1
N=1008 patients
N=1105 cycles (1.1 ± 1.1) Mean age=32.3 ± 2.2
50.9% of patients vitrified at 30‐36Y
Page 71 of 135
IVI unpublished data
Baseline characteristics COS parameters and IVF data
No Patients
No Cycles (mean)
Age at FP (mean)
No patients with previous children (%)
Protocol for Controlled Ovarian Stimulation
GnRH Antagonist (%) GnRH Agonist (%) Clomiphene (%) Letrozole (%)
Controlled Ovarian Stimulation Parameters
Length of stimulation Mean FSH dose (IU) Mean hMG dose (IU) Mean LH dose (IU)
E2 on day of hCG (pg/ml)
IVF data
No retrieved oocyte /patient (mean) No retrieved oocyte /cycle (mean) No MII vitrified /patient (mean)
No MII vitrified/cycle (mean)
4821
6467 (1.3 ± 1.9 ) 37.2 ± 4.9*
40
73.9* 8.9 15.6 1.4*
10.7 ± 7.1 1780.1 ± 972.3 1160.1 ± 1484.9 658.5 ± 159.1 1750.1 ± 38.9*
61380 (12.7 ± 7.4) 61380 (9.7 ± 8.4)* 47210 (9.8 ± 6.4) 47210 (7.3 ± 11.3)*
1041
1132 (1.1 ± 1.1) 32.3 ± 3.5*
3
22.2* 3.1 ‐ 77.7*
10.6 ± 21.2 1652.5 ± 2121.3 1077.6 ± 2916.8 689.6 ± 848.5 714.8 ± 310.4 *
12991 (12.4 ± 3.2) 12991 (11.4 ± 3.5)* 9931 (9.5 ± 2.6) 9931 (8.8 ± 2.1)*
*P<0.05
IVI unpublished data
EFP
Onco‐FP
Baseline Characteristics
PRECONGRESS COURSE 16 I BARCELONA, SPAIN – 1 JULY 2018 77